BALYASNY ASSET MANAGEMENT L.P. - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 139 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q4 2022$3,893,331
+1677.8%
167,816
+1480.5%
0.01%
+1000.0%
Q4 2019$219,000
-55.9%
10,618
-68.5%
0.00%
-50.0%
Q3 2018$497,000
+10.9%
33,712
+92.4%
0.00%0.0%
Q1 2018$448,00017,5200.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q4 2019
NameSharesValueWeighting ↓
Rubric Capital Management LP 1,926,283$40,105,0003.74%
Camber Capital Management LP 4,000,000$83,280,0002.20%
FRAZIER MANAGEMENT LLC 943,666$19,647,0001.76%
MANGROVE PARTNERS IM, LLC 593,741$12,362,0001.56%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 303,685$6,323,0001.07%
Eventide Asset Management 2,427,976$50,550,0000.99%
Avidity Partners Management LP 1,000,400$20,828,0000.97%
RICE HALL JAMES & ASSOCIATES, LLC 1,108,219$23,073,0000.93%
Perceptive Advisors 2,058,068$42,849,0000.63%
Rock Springs Capital Management LP 1,175,000$24,464,0000.62%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders